Reasons for exclusion from thrombolytic therapy following acute ischemic stroke

Dolores Cocho, R. Belvís, J. Martí-Fàbregas, L. Molina-Porcel, J. Díaz-Manera, A. Aleu, J. Pagonabarraga, D. García-Bargo, A. Mauri, J. L. Martí-Vilalta

Research output: Contribution to journalArticleResearchpeer-review

113 Citations (Scopus)

Abstract

Despite evidence for the efficacy of thrombolytic therapy in acute ischemic stroke, only 1 to 7% of patients receive this therapy. The authors sought to determine the reasons for exclusion from tissue plasminogen activator (tPA) in an acute setting and found avoidable causes in 18% of patients. Improvements in intrahospital coordination would increase the number of patients who might benefit from tPA treatment at the authors' center.
Original languageEnglish
Pages (from-to)719-720
JournalNeurology
Volume64
Issue number4
DOIs
Publication statusPublished - 22 Feb 2005

Fingerprint Dive into the research topics of 'Reasons for exclusion from thrombolytic therapy following acute ischemic stroke'. Together they form a unique fingerprint.

  • Cite this

    Cocho, D., Belvís, R., Martí-Fàbregas, J., Molina-Porcel, L., Díaz-Manera, J., Aleu, A., Pagonabarraga, J., García-Bargo, D., Mauri, A., & Martí-Vilalta, J. L. (2005). Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Neurology, 64(4), 719-720. https://doi.org/10.1212/01.WNL.0000152041.20486.2F